Simon D. Roger

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Sodium Zirconium Cyclosilicate in Hyperkalemia

David Packham, Henrik Rasmussen, Philip T. Lavin et al. · New England Journal of Medicine · 2014 · 493 citations · Full text

Medicine, Nephrology, Pharmacology +9

Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Catherine M. Clase, Juan Jesús Carrero, David H. Ellison et al. · Kidney International · 2019 · 477 citations · Full text

Medicine, Nephrology, Nutrition +17

Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt et al. · Kidney International · 2016 · 475 citations · Full text

Medicine, Hematology, Nephrology +17

Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis

Jill S. Lindberg, Bruce F. Culleton, Gordon Tin Chun Wong et al. · Journal of the American Society of Nephrology · 2005 · 409 citations

Medicine, Pharmacology, Pharmacotherapy +17